Literature DB >> 15840823

Complete, gene-specific siRNA libraries: production and expression in mammalian cells.

Attila A Seyhan1, Alexander V Vlassov, Heini Ilves, Levente Egry, Roger L Kaspar, Sergei A Kazakov, Brian H Johnston.   

Abstract

Short interfering RNAs (siRNAs) are widely used to silence the expression of specific genes. Current practice for designing effective siRNAs is to use algorithms based on sequence-efficacy correlations; however, there are many highly effective sequences that these algorithms do not anticipate. To ensure that the best siRNAs are identified, all possible gene-specific siRNA sequences of appropriate lengths should be screened in cell culture. Synthesizing and testing all such sequences individually is costly. A potentially much easier alternative is to prepare a mixture of all these sequences (a gene-specific library), express them in cells, select cells having the desired phenotype, and identify the siRNA contained within the selected cells. Here we describe two new methods for preparing and expressing such libraries. The first uses cloned Dicer or RNase III to digest gene-specific RNA duplexes to siRNAs, which are then converted to the corresponding DNA sequences by attaching RNA primers and performing reverse transcription-PCR. The second method involves partial DNase I digestion of gene-specific DNA, purification of a 20-30-bp fraction, and amplification by attaching DNA adapters followed by PCR. DNA libraries specific for TNF-alpha, DsRed, and part of the hepatitis C virus genome, generated by methods, were inserted into siRNA expression vectors between convergent human U6 and H1 promoters. Randomly selected clones from each library together with vectors expressing the corresponding target genes were cotransfected into 293FT cells and assayed for target gene inhibition. About 10%-20% of siRNAs represented in these libraries show significant inhibition of their target genes. Most of these inhibitory sequences are not predicted by existing algorithms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840823      PMCID: PMC1370768          DOI: 10.1261/rna.7285805

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  72 in total

1.  A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens.

Authors:  Andrew C Hsieh; Ronghai Bo; Judith Manola; Francisca Vazquez; Olivia Bare; Anastasia Khvorova; Stephen Scaringe; William R Sellers
Journal:  Nucleic Acids Res       Date:  2004-02-09       Impact factor: 16.971

2.  Enzymatic production of RNAi libraries from cDNAs.

Authors:  Daisuke Shirane; Kohtaroh Sugao; Shigeyuki Namiki; Mao Tanabe; Masamitsu Iino; Kenzo Hirose
Journal:  Nat Genet       Date:  2004-01-04       Impact factor: 38.330

3.  A protein sensor for siRNA asymmetry.

Authors:  Yukihide Tomari; Christian Matranga; Benjamin Haley; Natalia Martinez; Phillip D Zamore
Journal:  Science       Date:  2004-11-19       Impact factor: 47.728

4.  A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes.

Authors:  D W Leaman; A Salvekar; R Patel; G C Sen; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures.

Authors:  O Matveeva; B Felden; S Audlin; R F Gesteland; J F Atkins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

6.  Quantification of gene expression with a secreted alkaline phosphatase reporter system.

Authors:  T T Yang; P Sinai; P A Kitts; S R Kain
Journal:  Biotechniques       Date:  1997-12       Impact factor: 1.993

7.  Characterization of preferred deoxyribonuclease I cleavage sites.

Authors:  J E Herrera; J B Chaires
Journal:  J Mol Biol       Date:  1994-02-18       Impact factor: 5.469

8.  Shotgun DNA sequencing using cloned DNase I-generated fragments.

Authors:  S Anderson
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

9.  Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments.

Authors:  T A Holzmayer; D G Pestov; I B Roninson
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

10.  The effect of divalent cations on the mode of action of DNase I. The initial reaction products produced from covalently closed circular DNA.

Authors:  V W Campbell; D A Jackson
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

View more
  7 in total

1.  Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA polymerase.

Authors:  Antti P Aalto; L Peter Sarin; Alberdina A van Dijk; Mart Saarma; Minna M Poranen; Urmas Arumäe; Dennis H Bamford
Journal:  RNA       Date:  2007-01-19       Impact factor: 4.942

2.  Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model.

Authors:  Maria Jakobsen; Karin Stenderup; Cecilia Rosada; Brian Moldt; Søren Kamp; Tomas N Dam; Thomas G Jensen; Jacob Giehm Mikkelsen
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

3.  Size unbiased representative enzymatically generated RNAi (SURER) library and application for RNAi therapeutic screens.

Authors:  Tiejun Li; York Yuanyuan Zhu; Li Chen; Yuncheng Sun; Jian Yuan; Michael Graham; Peter French
Journal:  Nucleic Acid Ther       Date:  2014-12-10       Impact factor: 5.486

Review 4.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

5.  Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line.

Authors:  Si Ming Xie; Wei Yi Fang; Teng Fei Liu; Kai Tai Yao; Xue Yun Zhong
Journal:  J Oncol       Date:  2010-06-13       Impact factor: 4.375

6.  Single tube, high throughput cloning of inverted repeat constructs for double-stranded RNA expression.

Authors:  Brian Hauge; Christopher Oggero; Nicole Nguyen; Changlin Fu; Fenggao Dong
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

7.  Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.

Authors:  Si Ming Xie; Wei Yi Fang; Zhen Liu; Shuang Xi Wang; Xin Li; Teng Fei Liu; Wei Bing Xie; Kai Tai Yao
Journal:  J Transl Med       Date:  2008-10-04       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.